Familial Renal Cell Carcinoma with a 3;11 Chromosome Translocation Limited to Tumor Cells
Authors
Affiliations
Cytogenic studies were performed on the direct chromosome preparations of the renal cell carcinoma cells and the cultured peripheral blood lymphocytes of a patient with familial renal cell carcinoma. The results revealed a specific, acquired translocations (3p;11p) present in the majority of metaphases of the tumor, indicating that the development of renal cell carcinoma is associated with a deletion in the proximal end of 3p. Renal cell carcinoma is thus the third example--the first two being retinoblastoma and Wilms' tumor--of a chromosomal deletion occurring germinally or somatically in association with a specific tumor. This finding adds further support to the existence of specific human cancer genes.
Transient ischaemic attack secondary to paraneoplastic erythrocytosis.
Hurtarte Sandoval A, Flores Robles B, Andrus R, Yaxcal Chon D BMJ Case Rep. 2014; 2014.
PMID: 25336545 PMC: 4208132. DOI: 10.1136/bcr-2013-202572.
Genomic heterogeneity of translocation renal cell carcinoma.
Malouf G, Monzon F, Couturier J, Molinie V, Escudier B, Camparo P Clin Cancer Res. 2013; 19(17):4673-84.
PMID: 23817689 PMC: 3882157. DOI: 10.1158/1078-0432.CCR-12-3825.
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.
Clark P Kidney Int. 2009; 76(9):939-45.
PMID: 19657325 PMC: 2963106. DOI: 10.1038/ki.2009.296.
The von Hippel-Lindau gene: turning discovery into therapy.
Clark P, Cookson M Cancer. 2008; 113(7 Suppl):1768-78.
PMID: 18800388 PMC: 2963103. DOI: 10.1002/cncr.23645.
Understanding the natural biology of kidney cancer: implications for targeted cancer therapy.
Klatte T, Pantuck A, Kleid M, Belldegrun A Rev Urol. 2007; 9(2):47-56.
PMID: 17592537 PMC: 1892626.